Table 1.
Baseline characteristics of the patients with ASCVD and at high risks for ASCVD
| Characteristics | 2014 | 2015 | ||||||
|---|---|---|---|---|---|---|---|---|
| Patients to estimate prevalence | Patients to estimate incidence | Patients to estimate prevalence | Patients to estimate incidence | |||||
| Patients with ASCVD | ||||||||
| Number of patients | 4,073,832 | 2,431,291 | 4,235,437 | 2,535,664 | ||||
| Age at index (mean, SD) | 63.77 | 13.40 | 62.04 | 14.20 | 64.07 | 13.43 | 62.31 | 14.20 |
| Male (n, %) | 1,917,135 | 47.1% | 1,115,023 | 45.9% | 2,004,384 | 47.3% | 1,171,480 | 46.2% |
| Patients with diabetes | 4,742,145 | |||||||
| Patients with diabetes without ASCVD | ||||||||
| Number of patients | 4,189,371 | 1,368,326 | ||||||
| Age at index (mean, SD) | 60.87 | 13.38 | 57.22 | 14.68 | ||||
| Male (n, %) | 2,158,643 | 51.5% | 673,252 | 49.2% | ||||
| Patients with hypertension | 8,658,743 | |||||||
| Patients with hypertension without ASCVD | ||||||||
| Number of patients | 7,349,810 | 1,052,252 | ||||||
| Age at index (mean, SD) | 62.50 | 12.97 | 56.16 | 14.34 | ||||
| Male (n, %) | 3,605,515 | 49.1% | 581,354 | 55.3% | ||||
| Patients with dyslipidemia | 8,964,197 | |||||||
| Patients with dyslipidemia without ASCVD | ||||||||
| Number of patients | 7,809,475 | 3,265,877 | ||||||
| Age at index (mean, SD) | 57.21 | 14.11 | 52.45 | 15.16 | ||||
| Male (n, %) | 3,561,808 | 45.6% | 1,522,747 | 46.6% | ||||
ASCVD atherosclerotic cardiovascular disease, CCI Charlson Comorbidity Index, SD standard deviation, HIV human immunodeficiency virus, AIDS acquired immunodeficiency syndrome